EyePoint Pharmaceuticals, Inc. (36) | Business Finance (17)

Browse by Subcategory

Recent Contracts

Loan and Security Agreement, dated March 9, 2022, among EyePoint Pharmaceuticals, Inc., EyePoint Pharmaceuticals US, Inc., Icon Bioscience, Inc. and Silicon Valley Bank (Filed With SEC on March 14, 2022)
Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on November 19, 2021)
Underwriting Agreement, dated November 16, 2021, by and among EyePoint Pharmaceuticals, Inc. and Cowen and Company, LLC and Guggenheim Securities, LLC (Filed With SEC on November 19, 2021)
EyePoint Pharmaceuticals, Inc. 2019 Employee Stock Purchase Plan, as amended (Filed With SEC on June 24, 2021)
Royalty Purchase Agreement, dated December 17, 2020, by and between EyePoint Pharmaceuticals, Inc. and SWK Funding, LLC (Filed With SEC on March 12, 2021)
First Amendment to Share Purchase Agreement, dated February 1, 2021, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics (Filed With SEC on February 3, 2021)
Voting and Investor Rights Agreement, dated December 31, 2020, by and among EyePoint Pharmaceuticals, Inc., Ocumension Therapeutics, and EW Healthcare Partners, L.P. and EW... (Filed With SEC on January 4, 2021)
Fee Letter, dated February 13, 2019, by and between EyePoint Pharmaceuticals, Inc. and CRG Servicing LLC (Filed With SEC on February 19, 2019)
Amendment No. 3 and Waiver To Term Loan Agreement, dated May 3, 2021, among EyePoint Pharmaceuticals, Inc. as Borrower, EyePoint Pharmaceuticals US, Inc. and Icon Bioscience,... (Filed With SEC on May 5, 2021)
Underwriting Agreement, dated February 1, 2021, by and among EyePoint Pharmaceuticals, Inc. and Cowen and Company, LLC and Guggenheim Securities, LLC (Filed With SEC on February 3, 2021)
Share Purchase Agreement, dated December 31, 2020, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics (Filed With SEC on January 4, 2021)
Amendment No. 2 and Waiver To Term Loan Agreement, dated October 8, 2020, among EyePoint Pharmaceuticals, Inc. as Borrower, EyePoint Pharmaceuticals US, Inc. and Icon Bioscience,... (Filed With SEC on October 8, 2020)
Underwriting Agreement, dated February 21, 2020, by and between EyePoint Pharmaceuticals, Inc. and Guggenheim Securities, LLC (Filed With SEC on February 24, 2020)
Waiver To Term Loan Agreement, dated November 19, 2019, among EyePoint Pharmaceuticals, as Borrower, EyePoint Pharmaceuticals US, Inc. and Icon Bioscience, Inc., as subsidiary... (Filed With SEC on November 22, 2019)
EyePoint Pharmaceuticals, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on June 28, 2019)
Underwriting Agreement, dated March 28, 2019, by and between EyePoint Pharmaceuticals, Inc. and Guggenheim Securities, LLC (Filed With SEC on April 1, 2019)
Term Loan Agreement, dated February 13, 2019, among EyePoint Pharmaceuticals, Inc., as Borrower, EyePoint Pharmaceuticals US, Inc. and Icon Bioscience, Inc., as Subsidiary... (Filed With SEC on February 19, 2019)